down arrow

ERIS Lifescience

  • Market Cap: Mid Cap
  • Industry: Pharmaceuticals & Drugs
  • ISIN: INE406M01024
  • NSEID: ERIS
  • BSEID: 540596
INR
1,361.10
21.1 (1.57%)
BSENSE

Apr 11, 12:53 PM

BSE+NSE Vol: 1.29 lacs

  • Price Points
  • Score
  • Mojo Parameters
  • Total Return
  • News and Corporate Actions
  • Key factors
  • Shareholding
  • Financials
  • CompanyCV
stock-recommendationHalf Yearly Results
Results Snapshot
Figures in Rs cr
Consolidate Half Yearly Results
Sep'24
Sep'23
Sep'22
Sep'21
Sep'20
Sep'19
Net Sales
1,460.89
971.92
859.09
708.94
623.24
559.10
Other Operating Income
0.00
0.00
0.00
0.00
0.00
0.00
Total Operating income
1,460.89
971.92
859.09
708.94
623.24
559.10
Raw Material Cost
138.63
87.73
76.32
54.35
55.19
33.74
Purchase of Finished goods
243.92
92.97
106.60
71.25
88.64
41.11
(Increase) / Decrease In Stocks
-15.69
-7.71
7.90
9.66
-22.42
16.77
Employee Cost
258.25
202.67
173.35
127.20
117.10
97.66
Power Cost
0.00
0.00
0.00
0.00
0.00
0.00
Manufacturing Expenses
0.00
0.00
-0.01
0.01
0.00
-0.01
Selling and Distribution Expenses
0.00
0.00
0.00
0.00
0.00
0.00
Other Expenses
321.28
245.37
214.28
180.14
155.90
155.47
Total Expenditure (Excl Depreciation)
946.39
621.03
578.44
442.61
394.41
344.74
Operating Profit (PBDIT) excl Other Income
514.50
350.89
280.65
266.33
228.83
214.36
Other Income
6.19
4.47
7.91
12.85
3.42
8.00
Operating Profit (PBDIT)
520.69
355.36
288.56
279.18
232.25
222.36
Interest
119.84
33.65
14.30
1.85
0.86
1.42
Exceptional Items
0.00
0.00
0.00
0.00
0.00
0.00
Gross Profit (PBDT)
400.85
321.71
274.26
277.33
231.39
220.94
Depreciation
156.42
82.99
52.06
29.46
20.92
23.24
Profit Before Tax
244.43
238.72
222.20
247.88
210.47
197.69
Tax
58.66
22.76
9.75
22.83
13.74
20.93
Provisions and contingencies
0.00
0.00
0.00
0.00
0.00
0.00
Profit After Tax
185.77
215.96
212.45
225.05
196.74
176.77
Extraordinary Items
0.00
0.00
0.00
0.00
0.00
0.00
Prior Period Expenses
0.00
0.00
0.00
0.00
0.00
0.00
Other Adjustments
0.00
0.00
0.00
0.00
0.00
0.00
Net Profit
185.77
215.96
212.45
225.05
196.74
176.77
Share in Profit of Associates
0.00
0.00
0.00
0.00
0.00
0.00
Minority Interest
-11.00
2.32
2.43
0.00
0.00
-0.01
Other related items
0.00
0.00
0.00
0.00
0.00
0.00
Consolidated Net Profit
174.77
218.29
214.88
225.05
196.74
176.76
Equity Capital
13.61
13.60
13.60
13.59
13.58
13.75
Face Value
1.0
1.0
1.0
1.0
1.0
1.0
Reserves
0.00
0.00
0.00
0.00
0.00
0.00
Earnings per share (EPS)
12.84
16.05
15.8
16.56
14.49
12.86
Diluted Earnings per share
12.82
16.03
15.79
16.56
14.48
12.84
Operating Profit Margin (Excl OI)
35.37%
36.53%
33.12%
38.21%
37.31%
38.81%
Gross Profit Margin
27.56%
33.49%
32.37%
39.79%
37.73%
40.0%
PAT Margin
12.77%
22.48%
25.07%
32.29%
32.08%
32.0%
Public Share Holdings (%)
0.0%
0.0%
0.0%
0.0%
0.0%
0.0%
Pledged Promotor Holding (%)
0.0%
0.0%
0.0%
0.0%
0.0%
0.0%
Half Yearly Analysis Highlights
stock-summary

Net Sales

Growth in half year ended Sep 2024 is 50.31% vs 13.13% in Sep 2023

stock-summary

Consolidate Net Profit

Growth in half year ended Sep 2024 is -19.94% vs 1.59% in Sep 2023

stock-summary

Operating Profit (PBDIT) excl Other Income

Growth in half year ended Sep 2024 is 46.63% vs 25.03% in Sep 2023

stock-summary

Interest

Growth in half year ended Sep 2024 is 256.14% vs 135.31% in Sep 2023

stock-summary

Operating Profit Margin (Excl OI)

Growth in half year ended Sep 2024 has fallen from Sep 2023

Compare Half Yearly Results Of ERIS Lifescience With
Markets Mojo
Figures in Rs cr
Consolidate Half Yearly Results
Markets Mojo
Markets Mojo
Change(INR)
Change(%)
Net Sales
1,460.89
5,969.93
-4,509.04
-75.53%
Other Operating Income
0.00
0.00
0.00
Total Operating income
1,460.89
5,969.93
-4,509.04
-75.53%
Raw Material Cost
138.63
934.97
-796.34
-85.17%
Purchase of Finished goods
243.92
857.27
-613.35
-71.55%
(Increase) / Decrease In Stocks
-15.69
-104.82
89.13
85.03%
Employee Cost
258.25
1,280.21
-1,021.96
-79.83%
Power Cost
0.00
0.00
0.00
Manufacturing Expenses
0.00
0.00
0.00
Selling and Distribution Expenses
0.00
0.00
0.00
Other Expenses
321.28
1,470.50
-1,149.22
-78.15%
Total Expenditure (Excl Depreciation)
946.39
4,438.13
-3,491.74
-78.68%
Operating Profit (PBDIT) excl Other Income
514.50
1,531.80
-1,017.30
-66.41%
Other Income
6.19
210.03
-203.84
-97.05%
Operating Profit (PBDIT)
520.69
1,741.83
-1,221.14
-70.11%
Interest
119.84
18.01
101.83
565.41%
Exceptional Items
0.00
0.00
0.00
Gross Profit (PBDT)
400.85
1,723.82
-1,322.97
-76.75%
Depreciation
156.42
213.36
-56.94
-26.69%
Profit Before Tax
244.43
1,510.46
-1,266.03
-83.82%
Tax
58.66
314.99
-256.33
-81.38%
Provisions and contingencies
0.00
0.00
0.00
Profit After Tax
185.77
1,195.47
-1,009.70
-84.46%
Extraordinary Items
0.00
0.00
0.00
Prior Period Expenses
0.00
0.00
0.00
Other Adjustments
0.00
0.00
0.00
Net Profit
185.77
1,195.47
-1,009.70
-84.46%
Share in Profit of Associates
0.00
6.48
-6.48
-100.00%
Minority Interest
-11.00
-11.99
0.99
8.26%
Other related items
0.00
0.00
0.00
Consolidated Net Profit
174.77
1,189.96
-1,015.19
-85.31%
Equity Capital
13.61
40.06
-26.45
-66.03%
Face Value
1.00
1.00
0.00
Reserves
0.00
0.00
0.00
Earnings per share (EPS)
12.84
29.70
-16.86
-56.77%
Diluted Earnings per share
12.82
29.65
-16.83
-56.76%
Operating Profit Margin (Excl OI)
35.37%
25.66%
0.00
9.71%
Gross Profit Margin
27.56%
28.88%
0.00
-1.32%
PAT Margin
12.77%
20.13%
0.00
-7.36%
Public Share Holdings (%)
0.00%
0.00%
0.00
0.00%
Pledged Promotor Holding (%)
0.00%
0.00%
0.00
0.00%
Half Yearly - Net Sales
Net Sales 1,460.89 Cr
in Sep 2024

Figures in Rs Cr
stock-summary

Growth in half year ended Sep 2024 is 50.31% vs 13.13% in Sep 2023

Half Yearly - Consolidate Net Profit
Consolidate Net Profit 174.77 Cr
in Sep 2024

Figures in Rs Cr
stock-summary

Growth in half year ended Sep 2024 is -19.94% vs 1.59% in Sep 2023

Half Yearly - Operating Profit (PBDIT)
Operating Profit (PBDIT) 514.50 Cr
in Sep 2024

Figures in Rs Cr
stock-summary

Growth in half year ended Sep 2024 is 46.63% vs 25.03% in Sep 2023

Half Yearly - Interest
Interest 119.84 Cr
in Sep 2024

Figures in Rs Cr
stock-summary

Growth in half year ended Sep 2024 is 256.14% vs 135.31% in Sep 2023

Half Yearly - Operating Profit Margin (Excl OI)
Operating Profit Margin (Excl OI) 35.37%
in Sep 2024

Figures in Rs %
stock-summary

Growth in half year ended Sep 2024 has fallen from Sep 2023